Sponsor of the Day:
Jerkmate
https://www.astellas.com/en/about/astellas-integrated-report
Astellas Integrated Report | Astellas
Browse Astellas’ Annual Reports, now published as the Integrated Report, to see how we create long-term value for patients and stakeholders.
integrated reportastellas
https://www.microscope.healthcare.nikon.com/about/news/nikon-instruments-and-astellas-announce-a-strategic-collaboration-to-offer-sakulab-cambridge-resident-companies-access-to-advanced-imaging-capabilities-provided-by-nikon-bioimaging-lab-usa
Nikon Instruments and Astellas announce a strategic collaboration to offer SakuLab-Cambridge...
nikon instrumentsstrategic collaborationastellasannounceoffer
https://www.astellasventure.com/home/legal
Legal Disclaimer | Astellas Venture Management
The product information provided on astellas.com/us is intended for residents of the United States. Copyright © 2005 -2018 Astellas Pharma US, Inc. All rights...
legal disclaimerastellasventuremanagement
https://cafepharma.com/taxonomy/term/10989
Astellas | Cafepharma
astellascafepharma
https://www.astellas.com/en/science/medicines-and-disease-areas/medicines-by-location
Medicines by Location | Astellas
Explore Astellas' Medicines Availability page for transparent information on our pharmaceutical products across countries. Stay informed and check back for...
medicineslocationastellas
https://www.astellas.com/en/science
Science | Astellas
scienceastellas
https://www.astellasventure.com/
Astellas Venture Management | Astellas Venture Management
Gene Therapy Company | Rare Genetic Disease
astellasventuremanagement
https://www.statnews.com/2026/04/27/biotech-news-astellas-retries-xlmtm-gene-therapy-after-deaths/
Astellas, Eli Lilly, Veradermics, Compass: Readout Newsletter
Apr 27, 2026 - In today's biotech news: Veradermics' hair loss pill late-stage trial success, FDA fast-tracks reviews for psychedelics, and more
eli lillyreadout newsletterastellasveradermicscompass
https://www.astellas.com/en/science/medicines-and-disease-areas
Astellas Medicines, Products, and Therapeutic Areas | Astellas
Learn about Astellas’ portfolio of transformative therapies across oncology, immunology, urology, ophthalmology, and women’s health.
therapeutic areasastellasmedicinesproducts
https://www.astellas.com/en/investors/ir-library
IR Library | Astellas
Browse the Astellas IR Library for a calendar and archive of investor events, earnings calls, and financial reporting updates.
ir libraryastellas
https://www.astellas.com/en/science/research-and-development/open-innovation/sakulab-tsukuba
SakuLab-TsuKuba | Astellas
Learn about the SakuLab-Tsukuba open-innovation laboratory, located at Astellas’ Tsukuba Research Center in Tsukuba, Japan.
tsukubaastellas
https://www.astellas.com/en/about/patient-centricity/culture-and-integration
Culture and Integration | Astellas
Learn how the Culture and Integration Team creates an active and integrated culture of Patient Centricity across Astellas.
cultureintegrationastellas
https://www.astellas.com/en/science/research-and-development/open-innovation
Open Innovation in Drug Discovery | Astellas
Learn how Astellas is committed to fostering innovation with academia and startups by leveraging expertise from research and our global network.
open innovationdrug discoveryastellas
https://www.astellas.com/en/suppliers
Suppliers | Astellas
Current and prospective suppliers can find information relevant to working with and providing supplies and services to Astellas, globally.
suppliersastellas
https://www.astellas.com/en/about/ethics-and-compliance/astellas-culture-of-integrity
Astellas' Culture of Integrity | Astellas
astellascultureintegrity
https://newsroom.astellas.com/media-library
Global Media Library | Astellas
Check out the Astellas global media library to find the latest resources, assets and location information.
global medialibraryastellas
https://www.astellas.com/en/about/ethics-and-compliance/ethics-and-compliance-program-elements
Ethics and Compliance Program Elements | Astellas
Astellas' ethics and compliance program fosters a culture of integrity, empowering employees to make ethical decisions and deliver sustainable value to...
compliance programethicselementsastellas
https://www.astellas.com/en/sustainability/esg
ESG | Astellas
esgastellas
https://www.astellas.com/en/contact-us
Contact Information: Global Offices, Phone Numbers & Email | Astellas
Find global contact details for Astellas, including regional phone numbers, email addresses, and headquarters locations.
phone numbers emailinformation globalofficesastellas
https://www.biospace.com/astellas-xtandi-enzalutamide-granted-european-commission-approval-for-use-in-additional-recurrent-early-prostate-cancer-treatment-setting
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
Apr 23, 2024 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura,
european commissionastellasgrantedapprovaluse
https://www.astellas.com/en/science/research-and-development
Research and Development | Astellas
Astellas’ Research and Development strategy is driving a pipeline of transformative therapies, focusing on new targets with cutting-edge modalities.
researchdevelopmentastellas
https://www.astellas.com/en/sustainability/the-environment/ehs-management-and-disclosures-based-on-tcfd
EHS Management and Disclosures based on TCFD | Astellas
Learn more about the disclosure based on TCFD and EHS management at Astellas.
ehs managementdisclosuresbasedtcfdastellas
https://www.biopharmadive.com/news/astellas-again-hits-pause-on-gene-therapy-trial/605928/
Astellas again hits pause on gene therapy trial | BioPharma Dive
The company is holding off dosing more patients with AT132, a potential treatment for a deadly neuromuscular disease, after one recently experienced a serious...
gene therapy trialhits pausebiopharma diveastellas
https://www.astellas.com/en/science/research-and-development/pipeline
Pipeline | Astellas
Explore the Astellas clinical pipeline, including oncology and ophthalmology programs, and investigational therapies across other key areas.
pipelineastellas
https://transwestern.com/news-detail/astellas-hq
Astellas HQ
May 3, 2024 - OPPORTUNITY Over the course of a 15-year partnership, Transwestern has successfully completed over 2.7 million square feet of transactions and a total of 54...
astellashq
https://www.astellas.com/en/sustainability
Sustainability | Astellas
sustainabilityastellas
https://www.astellas.com/en/sustainability/the-environment/environmental-accounting-and-reporting-methods
Environmental Accounting and Reporting Methods | Astellas
Discover how Astellas calculates the costs of investment and expenses related to environmental conservation for its facilities in Japan and their outcomes.
environmentalaccountingreportingmethodsastellas
https://tradingeconomics.com/4503:jp:eps
Astellas Pharma | 4503 - EPS Earnings Per Share
Astellas Pharma reported JPY24.29 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.Data for Astellas Pharma | 4503 - EPS Earnings Per...
eps earnings perastellaspharma4503share
https://www.astellas.com/en/sustainability/astellas-and-society/our-people
Our People | Astellas
Learn how Astellas is building a workplace where diverse teams and individuals can thrive amid a culture of mutual learning and respect.
peopleastellas